Improving Efficacy and Maintaining Safety in the Treatment of Alopecia with Low-Dose Oral Minoxidil and Spironolactone Combination Therapy: A Retrospective Review

August 2024 in “ JAAD International ”

Ambika Nohria, Deesha Desai, Michelle Sikora, Nnaemeka Anyanwu, Avrom S. Caplan, Jerry Shapiro, Kristen Lo Sicco

low-dose oral minoxidil spironolactone androgenetic alopecia female androgenetic alopecia LDOM AGA

Studysummary This study aims to evaluate the efficacy and safety of combining low-dose oral minoxidil with spironolactone for treating female androgenetic alopecia, amid concerns about potential blood pressure effects, though the results are not reported here.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This retrospective study evaluated the efficacy and safety of low-dose oral minoxidil (LDOM) and spironolactone combination therapy for female androgenetic alopecia (AGA) in 21 patients at NYU Langone Health. The study found a trend toward increased hair density with combination therapy compared to monotherapy, although the difference was not statistically significant. Side effects were minimal, with only 1 patient experiencing dizziness, which resolved without medication changes. The study suggests that combination therapy may offer improved outcomes while maintaining safety, but acknowledges limitations such as small sample size and lack of blood pressure measurements. Further research is needed to fully understand the benefits and risks of this treatment approach.

View this study on jaadinternational.org →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis

August 2023 in “Cureus”

In a systematic review and meta-analysis, this study reported that oral spironolactone showed a 56.60% overall improvement in female pattern hair loss, with better results in combination therapy, but emphasized the need for more research due to varied treatment responses and adverse event rates.

research Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics

17 citations , November 2021 in “Journal of Cosmetic Dermatology”

This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.

research Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients

39 citations , February 2021 in “Journal of The American Academy of Dermatology”

In this study, low-dose oral minoxidil for hair loss was associated with infrequent systemic adverse effects, and only 1.7% of patients discontinued treatment due to these effects.

research Combination Oral Minoxidil and Spironolactone for the Treatment of Androgenetic Alopecia in Adolescent Girls

5 citations , December 2020 in “Journal of The American Academy of Dermatology”

This study observed objective improvement in androgenetic alopecia in 5 out of 6 adolescent girls treated with 2.5 mg oral minoxidil and spironolactone, and reported no adverse effects.

research Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone

80 citations , December 2017 in “International Journal of Dermatology”

This study reported that once-daily treatment with oral minoxidil and spironolactone for 12 months reduced hair loss severity and hair shedding in women with pattern hair loss, with generally mild side effects, though results came from an uncontrolled, observational pilot study.